Recurrence of clonal hematopoiesis after discontinuing pegylated recombinant interferon-alpha 2a in a patient with polycythemia vera.

Recurrence of clonal hematopoiesis after discontinuing pegylated recombinant interferon-alpha 2a in a patient with polycythemia vera. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Recurrence of clonal hematopoiesis after discontinuing pegylated recombinant interferon-alpha 2a in a patient with polycythemia vera. Abstract Text:

T Ishii,M Xu,Y Zhao,W-Y Hu,S Ciurea,E Bruno,R Hoffman,

Recurrence of clonal hematopoiesis after discontinuing pegylated recombinant interferon-alpha 2a in a patient with polycythemia vera. Publishing Authors By Initials

T Ishii,M Xu,Y Zhao,WY Hu,S Ciurea,E Bruno,R Hoffman,

For similar diagnosis: prognosis: treatment outcome research abstracts see: diagnosis: prognosis: treatment outcome research

PUBMED ID PMID:

MEDLINE DATE:

Recurrence of clonal hematopoiesis after discontinuing pegylated recombinant interferon-alpha 2a in a patient with polycythemia vera. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Leukemia : official journal of the Leukemia Societ

VOLUME: 21

Page Numbers: 373-4

Journal Abbreviation: Leukemia

ISSN: 0887-6924

DAY: 23

MONTH: 11

YEAR: 2006

Recurrence of clonal hematopoiesis after discontinuing pegylated recombinant interferon-alpha 2a in a patient with polycythemia vera. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8704895

Recurrence of clonal hematopoiesis after discontinuing pegylated recombinant interferon-alpha 2a in a patient with polycythemia vera. Keywords Mesh Terms:

KEYWORDS: Treatment Outcome

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: Recurrence of clonal hematopoiesis after discontinuing pegylated recombinant interferon-alpha 2a in a patient with polycythemia vera. Information

Substance Name: Janus Kinase 2

Registry Number: EC 2.7.1.112

Grant and Affiliation Information for Recurrence of clonal hematopoiesis after discontinuing pegylated recombinant interferon-alpha 2a in a patient with polycythemia vera.

AFFILIATION:

Country: England

AGENCY: United States NCI

GRANT: 1 P01 CA108671

ACRONYM: CA

MEDLINETA: Leukemia

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Recurrence of clonal hematopoiesis after discontinuing pegylated recombinant interferon-alpha 2a in a patient with polycythemia vera Related Publications

• Anti-inflammatory drug delivery from hyaluronic acid hydrogels.
• Bone morphogenetic protein-2 induces scar formation and skin maturation in the second trimester fetus.
• Characteristics of airflow in a CT-based ovine lung: a numerical study.
• Chemotherapy targets the hair-follicle vascular network but not the stem cells.
• Comparing the electronic properties of the low-spin cyano-ferric [Fe(N4)(Cys)] active sites of superoxide reductase and p450cam using ENDOR spectroscopy and DFT calculations.
• Connecting nitrogenase intermediates with the kinetic scheme for N2 reduction by a relaxation protocol and identification of the N2 binding state.
• Demonstration by 2H ENDOR spectroscopy that myo-inositol binds via an alkoxide bridge to the mixed-valent diiron center of myo-inositol oxygenase.
• Dynamic docking of cytochrome b5 with myoglobin and alpha-hemoglobin: heme-neutralization "squares" and the binding of electron-transfer-reactive configurations.
• EPR study of the low-spin [d(3); S =(1)/(2)], Jahn-Teller-active, dinitrogen complex of a molybdenum trisamidoamine.
• Effect of intoxication among blunt trauma patients selected for head computed tomography scanning.
• Effect of low-xenon and krypton supplementation on signal/noise of regional CT-based ventilation measurements.
• Examining histone acetlylation at specific genomic regions.
• GFP-expressing vascularization of Gelfoam as a rapid in vivo assay of angiogenesis stimulators and inhibitors.
• GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle.
• Hemangiomas and homeobox gene expression.
• How an enzyme tames reactive intermediates: positioning of the active-site components of lysine 2,3-aminomutase during enzymatic turnover as determined by ENDOR spectroscopy.
• In vivo color-coded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases.
• Mean length of utterance in children with specific language impairment and in younger control children shows concurrent validity and stable and parallel growth trajectories.
• Midline anterior craniofacial approach for malignancy: results of en bloc versus piecemeal resections.
• NMR spectroscopy can characterize proteins encapsulated in a sol-gel matrix.
• Prevention and treatment of vivax malaria.
• Rapid freeze-quench ENDOR study of chloroperoxidase compound I: the site of the radical.
• Recurrence of clonal hematopoiesis after discontinuing pegylated recombinant interferon-alpha 2a in a patient with polycythemia vera.
• Regional pulmonary blood flow in dogs by 4D-X-ray CT.
• Risk factors for asthma among cosmetology professionals in Colorado.
• Selective antimetastatic activity of cytosine analog CS-682 in a red fluorescent protein orthotopic model of pancreatic cancer.
• Surface-associated hsp60 chaperonin of Legionella pneumophila mediates invasion in a HeLa cell model.
• Survival efficacy of adjuvant cytosine-analogue CS-682 in a fluorescent orthotopic model of human pancreatic cancer.
• The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
• Visualization of nascent tumor angiogenesis in lung and liver metastasis by differential dual-color fluorescence imaging in nestin-linked-GFP mice.